Abstract
Several articles in this month's issue of the Journal advance what is known about attention-deficit/hyperactivity disorder (ADHD). Articles by Molina et al. ( p. 484 ) and Jensen et al. ( p. 501 ) provide new analyses of the landmark NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA). In the original MTA study, 579 children between 7 and 9.9 years old were randomized to 14 months of either systematic medication management with methylphenidate, multicomponent behavior therapy, combined medication plus behavior therapy, or community care.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.